Thiadiazinones

US5434149A · kind A · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Rochus Jonas · Darmstadt, DE
• Michael Klockow · Lutherstadt Eisleben, DE
• Hans-Jochen Schliep · Traisa, DE
• Michael Wolf · Darmstadt, DE

Key dates

• Filing date: Mar 31, 1994
• Grant date: Jul 18, 1995
• Expiry date: Mar 31, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to thiadiazinones of the formula I ##STR1## having a phosphodiesterase-inhibiting action and which are suitable for combating cardiovascular and asthmatic disorders.